Cough Syrup Recall Sparks Nationwide Warning
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Medtech Products Inc. is recalling the Little Remedies brand of Honey Cough Syrup due to fears the product may be contaminated with Bacillus cereus bacterium and concern over the product's shelf-life stability.
Newsweek reached out to the company via email Wednesday for comment.
Why It Matters
Numerous recalls have been initiated in 2025 due to the potential of damaged products, foodborne illness, contamination and undeclared food allergens.
Millions of Americans experience food sensitivities or allergies every year. According to the Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts.
The FDA also warns that people who consume products containing Bacillus cereus may experience nausea, vomiting or stomach cramps from one to six hours after consumption or eight to 16 hours later.
"Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death," the alert warns.
What To Know
In the alert, the FDA says the recalled product was distributed online and to nationwide retailers from December 14, 2022, to June 4, 2025.
The alert has a chart showing UPC numbers with corresponding lot numbers and expiration dates for customers to reference.
The recalled product was packaged in 4-fluid ounce bottles that are amber in color with an outside carton. Pictures of the recalled cough syrup are also in the FDA alert.
The recall does not include other Little Remedies products, the agency says, adding that all lots of the Little Remedies Honey Cough 4-fluid ounce bottles "still within expiry are being included in the scope of the recall."
There have been no "serious adverse events" related to the recall as of Wednesday, according to the FDA.
What People Are Saying
The FDA alert, in part: "Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Complete and submit the report Online: www.fda.gov/medwatch/report.htm
Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178."
What Happens Next
Customers who have purchased the recalled cough syrup are advised to stop using the product and consult a medial professional if experiencing adverse reactions, the FDA says.
Those with refund questions may contact the company via email at medicalaffairs@prestigebrands.com, by website at https://www.prestigebrands.com/contactExternal Link Disclaimer or via phone at (800) 754-8853 from 8:30 a.m. to 5:30 p.m. ET weekdays.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Politico
an hour ago
- Politico
RFK Jr.'s past claims shadow vaccine panel agenda
Presented by With help from Amanda Chu and Danny Nguyen Driving the Day ACIP AGENDA CHANGE — The agenda for next week's Advisory Committee on Immunization Practices meeting includes some notable differences from the notice posted in the Federal Register earlier this month, Sophie reports with POLITICO's Lauren Gardner. Most notably, the panel will hold two separate votes for the flu shot: one on influenza vaccines and another on influenza vaccines that contain thimerosal. In 2014, before he became health secretary, Robert F. Kennedy Jr. wrote a book in which he alleges the vaccine preservative thimerosal likely caused autism and should be banned — a claim that health agencies now under his control have said is unfounded. Thimerosal continues to be used as a preservative in multidose vaccine vials to inhibit germ growth. But its use in FDA-licensed flu vaccines has declined over the past 25 years as manufacturers reformulated their products and shifted to single-use vials. Most of those contain little or no thimerosal, according to the CDC. The meeting marks the first for Kennedy's revamped ACIP roster — following the firing of the previous 17 members — which includes several vaccine skeptics. No Covid vote: The agenda does not include a vote on Covid-19 vaccines, despite the Federal Register notice saying a vote is planned. Last month, Kennedy updated the CDC's Covid recommendations without a vote from the panel, breaking from tradition. Kennedy removed the recommendation that pregnant women get the shot, and the CDC changed the recommendation for healthy children to 'shared clinical decision making' — meaning children 'may' get vaccinated if their doctors and parents want them to. The HPV vaccine and meningococcal vaccine were also slated for a vote according to the meeting's Federal Register notice but aren't included in the draft agenda. Cut short? The agenda for the advisory committee's meeting includes only two days, June 25 and 26, but the initial Federal Register notice said the panel would also meet on June 27. A spokesperson for HHS did not comment on the thimerosal vote or why the agenda for the 27th wasn't included. WELCOME TO FRIDAY PULSE. For more on what next week's ACIP agenda holds, keep reading. Send your tips, scoops and feedback to khooper@ and sgardner@ and follow along @Kelhoops and @sophie_gardnerj. Vaccines 'THEY CROSSED THE LINE' — Dr. Fiona Havers, a CDC scientist who collected and compiled data on Covid-19 and respiratory syncytial virus before stepping down this week, told POLITICO that HHS Secretary Robert F. Kennedy Jr.'s overhaul of the agency's outside panel of vaccine experts was her final straw. 'I knew at that point that they had crossed the line,' Havers said. 'As a physician and a scientist, and for my own personal integrity, I did not feel like I could stay and legitimize this process.' The Advisory Committee on Immunization Practices votes on vaccine recommendations, playing an integral role in developing childhood and adult vaccine schedules. Last week, Kennedy fired the entire panel and replaced them with members he hand-selected. The first meeting of the new members is scheduled for next week. Havers often presented data to the panel to inform its decisions. I spoke with Havers about her decision to resign and what she will be watching for at next month's meeting. Here's our conversation, edited for length and clarity. What made you resign? [It was a] culmination over the last one to two months of RFK Jr. trashing the vaccine policy recommendation process at CDC. This has been building for a while. Several events have really undermined the vaccine policy process. One was in late May, when FDA officials released this regulatory framework suggesting that only those 65 years older and people with underlying medical conditions should receive [updated] Covid-19 vaccines. Then the following week, the HHS secretary announced on X that the Covid vaccines for healthy children and healthy pregnant women had been removed from the CDC recommended vaccine immunization schedule … Basically, RFK Jr. was making CDC vaccine policy on X without involving CDC. And that was pretty shocking, because there's a very rigorous process in place. Then last week, when they announced the firing of all 17 ACIP members, I knew I was done. Can you share any thoughts on Kennedy's replacement picks? These people are, for the most part — with very few possible exceptions — not the people that should be sitting on ACIP. What will you be watching at the meeting next week? If CDC is presenting the data … the data coming out of CDC is still solid. As of now, I can speak to the fact that the COVID-NET and RSV-NET data is high-quality evidence and can be believed. How those data get used to make vaccine policy decisions is really what's in question right now. Seeing the kind of questions that they ask and what they say may give some clue as to how they may vote in the future. I am very concerned that there's going to be a restricting of access to vaccines for people that otherwise should be getting them, and we'll get some sense of if that's actually going to happen. HHS response: HHS spokesperson Andrew Nixon told POLITICO that HHS is 'committed to following the gold standard of scientific integrity,' and 'vaccine policy decisions will be based on objective data, transparent analysis and evidence — not conflicts of interest or industry influence.' AROUND THE AGENCIES GAIN-OF-FUNCTION CUTS — The National Institutes of Health is cutting and suspending funding for gain-of-function research, a move that will impact biomedical projects conducted globally, Danny reports. The NIH's directive, released Wednesday, will immediately terminate funding and other support for gain-of-function research conducted by 'foreign entities in countries of concern or foreign countries where there is no adequate oversight.' The order didn't explicitly name the targeted groups and countries. The NIH did not respond to a request for comment. The agency will also suspend funding and additional support for all other gain-of-function research and has asked researchers who receive NIH funds to identify other projects not yet identified by the agency that fit the category by June 30. Gain-of-function research involves genetically altering biological organisms to enhance transmission or other functions, which can help scientists identify therapeutic targets. Key context: The move comes months after the Trump administration marked gain-of-function research as dangerous. Earlier this year, the administration said the Covid pandemic was caused by a lab leak from gain-of-function research at a virology research institute in the Chinese city of Wuhan, where the virus first appeared. Many scientists, however, believe the disease was caused by natural spillover from an animal to a human. The Trump administration's theory, memorialized in a glossy website unveiled in April, prompted President Donald Trump to issue an executive order last month to eliminate federal funding for gain-of-function research in countries such as China, which Trump has criticized for inadequate research oversight. The NIH's latest missive delivers on this executive order. In other research news: The FDA announced Wednesday it would immediately review new clinical trials that 'involve sending American citizens' living cells to China and other hostile countries for genetic engineering and subsequent infusion back into U.S. patients — sometimes without their knowledge or consent.' The order, endorsed by the NIH, is another swipe at foreign research — particularly studies performed in China, which the administration has characterized as poorly regulated. Industry Intel BURR'S LOBBYING GIG — The Biotechnology Innovation Organization, the world's largest biotech organization, has tapped former Republican Sen. Richard Burr (R-N.C.) to lobby on issues related to drug pricing and supply chains, Medicare and Medicaid and reauthorization of the Pandemic and All-Hazards Preparedness Act, Amanda reports. Now health policy chair at law firm DLA Piper, Burr was the top Republican on the Senate Health, Education, Labor and Pensions Committee and was a champion of reforming the FDA. Jamie Gregorian, a former senior policy adviser at the FDA and assistant to Burr in the Senate, will also represent BIO at DLA Piper, according to the law firm's disclosure submitted today. The outside hire from BIO marks the third for the group this year and comes as the biotech industry faces a steep drop in investor funding amid President Donald Trump's cuts to regulatory agencies. Earlier this week, BIO hired former Trump White House adviser Matt Mowers and Trump's campaign deputy director Bill Killion, who both now work at Valcour, a Washington-based lobbying firm. WHAT WE'RE READING POLITICO's Jordain Carney and Robert King report that Senate Republican leaders are seeking ways to tamp down moderates' worries about the megabill's possible impact on rural hospitals. The New York Times' Roni Caryn Rabin reports on the Trump administration's travel restrictions impacting medical residents.
Newsweek
an hour ago
- Newsweek
Chocolates Recalled From Stores Nationwide
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Chocolate products distributed throughout the United States have been recalled. Weaver Nut Company recalled its semi-sweet chocolate nonpareils with white or Christmas-colored seeds, with specific lot codes, because of potential undeclared milk allergens, the company said in a news release published by the U.S. Food and Drug Administration (FDA) on Wednesday. "People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reactions if they consume the impacted products," it added. No illnesses have been reported as of the recall date, it said. Newsweek contacted the company via email for the latest update on Friday. Stock photo of chocolate. Stock photo of chocolate. Getty Images Why It Matters Milk is one of the top nine allergens required to be declared by the FDA, and incorrect labeling can put lives at risk, particularly for people with milk allergies or severe sensitivities. What To Know The products were distributed through retail and grocery outlets across the U.S., and consumers are urged to check product lot codes and return or discard any affected items. Weaver's Angela Nolt said the company "is taking all necessary steps to ensure the safety of its products." The issue was identified after a wholesale customer submitted a complaint regarding discrepancies with product specifications, the FDA said in its release. Subsequent laboratory testing confirmed the presence of milk proteins in the chocolates, which were labeled as free from milk, it added. The affected chocolate nonpareils were distributed across the United States and sold through various grocery and retail chains. Weaver Nut Company, based in Pennsylvania, said that the recall is a precautionary measure to safeguard public health. The FDA release included pictures of the products: (from left) Nonpareil, Semi-Sweet Chocolate (Christmas seeds) and Nonpareils, Semi-Sweet Chocolate (white seeds). The FDA release included pictures of the products: (from left) Nonpareil, Semi-Sweet Chocolate (Christmas seeds) and Nonpareils, Semi-Sweet Chocolate (white seeds). Weaver Nut Company Products and Lot Codes Involved Item 47518 - Nonpareil, Semi-Sweet Chocolate (Christmas Seeds): Lot numbers 204206, 204207, 204208, 204209, 204212, 224225 Item D2645 - Nonpareils, Semi-Sweet Chocolate (White Seeds): Lot numbers 204214-RL, 204214, 204215, 224221, 224222, 224223, 135215, 135216, 135217, 135220, 135221, 145204, 145205-1, 145207-1, 145210-1 Consumers who purchased the affected items and have a milk allergy or are purchasing for someone who does are urged not to consume them, the recall notice said. Products should be returned to the place of purchase for a full refund or discarded. Refunds will be provided regardless of package status (opened or unopened), it added. What Happens Next Weaver Nut Company and the FDA will continue investigating the cause of the undeclared milk and monitor for any reports of illness. Consumers may contact the company directly for updates or further instructions pending regulatory review. For further assistance, consumers can contact Chris Westerhoff, customer service manager at Weaver Nut Company, at 717-738-3781, extension 122, or by email at cwesterhoff@ Monday through Friday from 9 a.m. to 4:30 p.m. ET.
Newsweek
an hour ago
- Newsweek
Dwarf Cat With Only 2 Teeth Can't Stop Tongue Hanging Out—And It's Adorable
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Internet users can't get enough of an adorable cat whose tongue is perpetually hanging out of his mouth due to having so many of his teeth removed. Otis the 8-month-old cat has captured hearts online with his adorable expressions and his tongue sticking out that makes him look like a real-life emoji. While still only young, he's had to have almost all his teeth removed, leaving him with just two canines left—and they'll have to be removed in the future too. As a result, Otis's tongue no longer stays within his mouth, and his owner Kate, from London, U.K., tells Newsweek that she's "not sure if it ever will" again. From a young age, Otis was diagnosed with dwarfism and feline calicivirus (FCV), a highly contagious virus that can cause upper respiratory infections and oral disease. This virus caused Otis to develop stomatitis, which is severe inflammation of the mouth and gum tissue around the teeth. Otis the 8-month-old cat, with dwarfism, showing his tongue sticking out. Otis the 8-month-old cat, with dwarfism, showing his tongue sticking out. @otisthedwarfcat / TikTok Kate, 20, explained that Otis's gums "began growing over his teeth," alongside a lot of bleeding and intense pain. It was so difficult for Otis to eat anything, and the only option was tooth extraction. "Otis had to have almost all his teeth removed, except for two of his canines. Despite everything, he's recovering and adapting really well since his dental procedures," Kate said. While his appearance may be different, Otis has become quite the viral sensation on TikTok. Kate has been sharing videos of her sweet kitten on his dedicated social media account (@otisthedwarfcat), and one clip of her "poor little baby" has generated over 1.5 million views and 323,700 likes at the time of writing. The online reaction is beyond anything Kate expected, but she's been so heartened by all the love and support shown towards her little warrior. She told Newsweek: "I thought he looked adorable in the video, but it was also heartbreaking to see him like that. He's so young and it felt so unfair for him to go through so much. "I'm really touched by how many people are loving the video of him. It makes me happy not only to share his journey, but also to raise awareness about calicivirus and how seriously it can affect cats." In the months ahead, Otis will need one final dental procedure to remove his remaining teeth. But he's remained strong throughout every challenge he's faced so far, and Kate says she's immensely proud of him. After the video went viral showing Otis with his tongue perpetually hanging out, hundreds of social media users took to the comments to praise his quirky expression. This has led to more than 760 comments on TikTok so far, with many even suggesting which emoji he resembles the most. One comment reads: "that's so sad, but that's the cutest thing I've ever seen." Another TikTok user wrote: "He looks like he's constantly emoting lol." Another person added: "I hope he knows how cute he is." While one commenter joked: "he's just permanently silly now." Do you have funny and adorable videos or pictures of your pet you want to share? We want to see the best ones! Send them in to life@ and they could appear on our site.
